Teriflunomide 62332-0314-91
- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 25, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA209572
Need to source Teriflunomide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Teriflunomide | 14 mg/1 |
Drug Class
Pyrimidine Synthesis Inhibitor [EPC]Dihydroorotate Dehydrogenase Inhibitors [MoA]Pyrimidine Synthesis Inhibitor [EPC]
Selected Package
62332-0314-91Selected1000 TABLET, FILM COATED in 1 BOTTLE (62332-314-91)
Other packages for this product(2)
2 BLISTER PACK in 1 CARTON (62332-314-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK
30 TABLET, FILM COATED in 1 BOTTLE (62332-314-30)